Eastman Chemical (EMN) Asset Writedowns and Impairment (2009 - 2025)

Eastman Chemical (EMN) has reported Asset Writedowns and Impairment for 11 consecutive years, with $33.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $33.0 million; the trailing twelve-month figure through Dec 2025 stood at $38.0 million (up 660.0% YoY), and the FY2025 full-year result was $33.0 million, up 560.0% from the prior year.
• Asset Writedowns and Impairment grew to $33.0 million in Q4 2025 per EMN's latest filing, from $5.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $33.0 million in Q4 2025 and bottomed at $5.0 million in Q2 2021.
• Historically, Asset Writedowns and Impairment has averaged $13.5 million across 3 years, with a median of $8.0 million in 2021.
• The widest YoY moves for Asset Writedowns and Impairment: up 1000.0% in 2021, down 96.32% in 2021.
• Over 3 years, Asset Writedowns and Impairment stood at $11.0 million in 2021, then plunged by 54.55% to $5.0 million in 2024, then jumped by 560.0% to $33.0 million in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $33.0 million, $5.0 million, and $11.0 million for Q4 2025, Q3 2024, and Q4 2021 respectively.